Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24‐Month Follow‐Up

Publisher: John Wiley & Sons Inc

E-ISSN: 1525-1403|18|5|397-403

ISSN: 1094-7159

Source: NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol.18, Iss.5, 2015-07, pp. : 397-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract